Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00165438 · ClinicalTrials.gov registry record
Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy
A clinical trial, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- 60
- Enrollment target
NCT00165438: Completed study, sponsored by Dana-Farber Cancer Institute.
NCT00165438 is a clinical trial that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00165438 has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to find out the impact Bleomycin-containing chemotherapy, given with or without chest radiation therapy, on patients' lung function over time.
Primary Outcome
Changes in pulmonary function over time
Interventions
- PROCEDURE Pulmonary Function Tests
- PROCEDURE CAT Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2001-10 |
| Est. Completion | 2010-01 |
What the finished NCT00165438 record still lists
NCT00165438 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Pulmonary Function Tests is the first listed.
NCT00165438 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00165438 about?
NCT00165438 is a clinical study titled "Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy". The purpose of this study is to find out the impact Bleomycin-containing chemotherapy, given with or without chest radiation therapy, on patients' lung function over time.
What is the current status of trial NCT00165438?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2001-10. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00165438?
The interventions under investigation include: Pulmonary Function Tests (PROCEDURE), CAT Scan (PROCEDURE).
Who is sponsoring clinical trial NCT00165438?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia